Researchers are exploring new therapeutic strategies to tackle metastatic prostate cancer, particularly those cases resistant to standard chemotherapy treatment with docetaxel.

First Black in-state graduate recalls a lifetime of persevering to build a legacy in Tucson.

UArizona has been named a member of the Age-Friendly University Global Network, a group of higher education institutions committed to promoting positive and healthy aging and enhancing the lives of older members of the global community.

A profile of People Acting Now Discover Answers, or PANDA, a Phoenix-based women’s philanthropy board that raises awareness and funds to benefit research for childhood diseases through the Steele Children’s Research Center at the College of Medicine – Tucson.

A profile of a girl treated for VACTERL syndrome, a disorder that affects many body systems.

Mark R. Barakat, MD, clinical assistant professor in the Department of Ophthalmology at the College of Medicine – Phoenix, will share first time results of the KSI-501ABC Phase 1 Study at the Angiogenesis, Exudation, and Degeneration 2024 virtual meeting Feb. 3.

University of Arizona Cancer Center member Noel Warfel, PhD, co-led a research team that created and patented technology to combat anti-cancer drug resistance.

Before the MILAGRO Collaborative became a course for students, UArizona faculty stood up to help the less fortunate.

As part of the Health Sciences Design course MILAGRO Collaborative, faculty and students provide much-needed services to migrants in Tucson.